Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
about
Approved Antiviral Drugs over the Past 50 YearsA Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.Recurrent severe anaemia: a rare presentation of parvovirus b19 infection.Parvovirus B19 infection presenting with severe erythroid aplastic crisis during pregnancy in a woman with autoimmune hemolytic anemia and alpha-thalassemia trait: a case report.American society of Nephrology Quiz and Questionnaire 2014: transplantation.Congenital Parvovirus B19 Infection: Persistent Viremia and Red Blood Cell AplasiaHereditary Spherocytosis Unmasked by Human Parvovirus B19 Induced Aplastic Crisis in a FamilyCollapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigationAnemia of Central Origin.Prevalence of neutralizing antibodies to common respiratory viruses in intravenous immunoglobulin and in healthy donors in southern China.Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous ImmunoglobulinHaematological manifestations of human immune deficiency virus infection.Spectrum of anemia after kidney transplantation: pathophysiology and therapeutic implications.Pure red cell aplasia caused by parvovirus B19 in a heart transplant recipient.Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem cell transplantation and severe graft versus host disease.Persistent and Prolonged Parvovirus B19 Viremia in a Pediatric Patient With Acute Lymphoblastic Leukemia.Spectrum of adult Parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice.Persistent pure red cell aplasia in dicygotic twins with persistent congenital parvovirus B19 infection-remission following high dose intravenous immunoglobulin.A case of parvovirus B19-induced pure red cell aplasia in a child following heart transplant.Costs of intravenous immunoglobulin therapy in patients with unconfirmed parvovirus b19 pure red cell aplasia.Rational management approach to pure red cell aplasia.Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant.Parvovirus B19-triggered Acute Hemolytic Anemia and Thrombocytopenia in a Child with Evans Syndrome.Extra-haematological manifestations related to human parvovirus B19 infection: retrospective study in 25 adults.Parvovirus B19 Achievements and ChallengesClinical heterogeneity of human parvovirus B19 infection following adult liver transplantation
P2860
Q27755387-CF17124D-37E8-4EF0-830C-69B1CCA2F9C3Q33439333-FED72BCE-8D50-4EA4-950C-C1C3132118F4Q33783400-2717DA1D-DBD8-4345-BE55-886D8615F0EEQ35186288-D2832E51-F633-4BEC-B806-CA5B1CA37AE9Q35576167-5711563E-7FC4-4427-9E25-794377A0E74BQ35964797-DC18FE57-81A9-4CFF-9A89-48C39EC5232AQ36053430-3171E367-C2AF-43E4-AD5D-6A8A8D73F188Q36124605-4F06E91E-B428-4A15-9417-DF5FA6AB72BAQ36784115-2F4AA917-2E32-4B92-A0EA-F1B8A77A52F8Q36829831-B9A66687-2187-4BF4-ADE9-E8BCF97BDD30Q37738744-5D4EF454-AB49-4500-B126-BBDD9D0B8E78Q38603109-3C993515-4D07-4904-99D1-2615213B7F29Q38900551-2FD1CFD2-285C-491E-B299-1B0C663815D3Q40573937-6E536A7C-4EC3-4630-92C9-1A4F2C0C7C15Q40697247-F012597E-4D90-403A-806A-74E870599A3DQ40981362-84575928-A4A5-464D-BFC0-DEC69995D993Q41277749-DCFA5F24-0668-442E-8B88-D94D2DFEE4CAQ41721092-E8C19D59-39DC-4622-BB2B-6BA0AB84CD16Q42236069-22687133-9895-4970-9AE0-82330AFC4207Q43732885-185E2407-3792-4951-B63C-F7DD0E024CD9Q47584782-3209E3CF-BE58-4A52-9292-378B994AEDC8Q48098399-63522443-12AF-4E63-AA21-3E733E18936FQ54257241-6AF4347A-94E3-4DDF-99ED-25D6A2EB61E6Q55547413-FFF07B29-4983-42F8-A641-660A1AE33502Q58666387-352919AD-35E7-4F78-A88C-FDA78213B2E8Q58706529-F86810DB-48D9-4326-BE10-20938A5AE1A1
P2860
Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intravenous immunoglobulin the ...... and review of the literature.
@ast
Intravenous immunoglobulin the ...... and review of the literature.
@en
Intravenous immunoglobulin the ...... and review of the literature.
@nl
type
label
Intravenous immunoglobulin the ...... and review of the literature.
@ast
Intravenous immunoglobulin the ...... and review of the literature.
@en
Intravenous immunoglobulin the ...... and review of the literature.
@nl
prefLabel
Intravenous immunoglobulin the ...... and review of the literature.
@ast
Intravenous immunoglobulin the ...... and review of the literature.
@en
Intravenous immunoglobulin the ...... and review of the literature.
@nl
P2093
P2860
P356
P1476
Intravenous immunoglobulin the ...... and review of the literature.
@en
P2093
Benjamin Terrier
Catherine Montagnier-Petrissans
Christophe Legendre
Flore Rozenberg
Groupe d'experts de l'Assistance Publique-Hôpitaux de Paris
Loïc Guillevin
Luc Mouthon
Vincent Pestre
Yoann Crabol
P2860
P304
P356
10.1093/CID/CIS1046
P407
P577
2012-12-12T00:00:00Z